As promised, Amarin submitted its US new drug application (NDA) seeking approval to market its fish oil pill AMR101 as a treatment for patients with very high triglycerides – holding to its word to get the application filed this quarter.
As promised, Amarin submitted its US new drug application (NDA) seeking approval to market its fish oil pill AMR101 as a treatment for patients with very high triglycerides – holding to its word to get the application filed this quarter.
